The article written by Romero-Aroca et al. (2017) dwelled at the occurrence of diabetic retinopathy and numerous risk factors that were associated with this disease and some other diseases such as diabetic macular edema and sight-threatening diabetic retinopathy. So as to evaluate these risks, the researchers developed a specific screening program and conducted an extensive study on the subjects. In order to conduct an efficient investigation, Romero-Aroca et al. (2017) considered several risk factors that were the most prevalent (cholesterol fraction, age, serum creatinine, and the respondent’s sex).
We will write a custom Term Paper on Differences in Incidence of Diabetic Retinopathy specifically for you
807 certified writers online
The results of the study showed that the yearly occurrence of diabetic retinopathy did not exceed 48%. On the other hand, the level of occurrence of sight-threatening diabetic retinopathy did not exceed 19%, and the yearly percentage was way lower than in the patients with diabetic retinopathy. The lowest yearly occurrence was found in patients with diabetic macular edema – 9%. The analysis of the results of the study helped the researchers to expose the finding that age was one of the most insignificant factors that contributed to the incidence of diabetic retinopathy.
Also, Romero-Aroca et al. (2017) identified that patients with type 1 diabetes mellitus were more inclined to have diabetic retinopathy and sight-threatening diabetic retinopathy. The researchers also found that an inadequate metabolic control of diabetes mellitus unfavorably impacted the manifestation of diabetic retinopathy in type 1 diabetes mellitus patients. Romero-Aroca et al. (2017) claimed that further research in the area is necessary in order to mitigate the occurrence of the reviewed ailments and treat numerous complications associated with diabetic retinopathy.
Based on the reviewed articles, it is safe to say that the importance of patient-based care is a rather relevant topic nowadays. If we understand disorders and diseases, we will be able to maintain the quality of health care. It can be told that the peculiarities of different diseases can be assessed as a possibility to research different subjects way more than before and concentrate on patient-centered care so as to help healthcare providers expand their knowledge base and improve their medical practice.
Therefore, if we address the question of recognizing disorders, we will positively influence the provision of patient-centered care and increase the possibility of treating the ailments successfully. The factors that were mentioned above are expected to impact insurance expenditures as well because the notion of “patient-centered care” is inextricably linked to understanding what, how, and when to treat. This area of health care is revolutionary, and it is critically important to take it into consideration when discussing the issues related to health care and health care providers. Nonetheless, one should understand that the work of any given health care provider is full of different moral implications and it cannot exist without mutual respect and sacrifice-based care.
The understanding of an illness or a disorder depends on the ideas that are characteristic of health care providers when it comes to treating patients as exceptional living beings. Also, it is safe to say that the existing principles and guidelines relatively force health care providers to fulfill their obligations and perform an in-depth analysis of the patients’ diseases and backgrounds before starting the treatment process. As it can also be seen from the article written by Lorvan, Agah, Mousavi, Hosseini, and Shidfar (2016), one of the key factors that contribute to the differentiation between diseases and ailments and the provision of high-quality patient-based care is the involvedness of the customers in both research and care processes. The social and personal contexts of health care have to be taken into consideration when there is a need for high-quality services. Evidently, the notion of health care should not be a simple wish-gratifying journey for each and every patient, but the individual focus of patient-centered care is one of the factors that positively affect the development of evidence-based treatments and cover major populations.
If we understand diseases and disorders, we will be able to realize the meaning of putting the patients (and not only research) at the forefront of health care. Benli et al. (2017) implicitly addressed this issue and discussed the generalization of research results as one of the ways of promoting patient-centered care that is supported by relevant evidence. Numerous health care providers agree that the act of recognizing disorders is also heavily influenced by social changes that cannot be ignored by the health care industry.
Also, it is repeatedly stated that the extent to which the patients are involved in the process of their treatment also significantly influences the provision of care and understanding of diseases. By making the patients more willing to participate in research, we will be able to get to the next level of health care where patients are an irreplaceable part of the treatment process, and the ultimate understanding of the disease will partly depend on the patients and not only physicians. The current state of health care is seriously contingent on research and feedback from the patients so understanding the details of diseases and disorders cannot be overlooked within the framework of the current health care environment.
Benli, A. R., Erturhan, S., Oruc, M. A., Kalpakci, P., Sunay, D., & Demirel, Y. (2017). A comparison of the efficacy of varenicline and bupropion and an evaluation of the effect of the medications in the context of the smoking cessation programme. Tobacco Induced Diseases, 15(1), 1-13. doi:10.1186/s12971-017-0116-0.
Lorvan, A., Agah, S., Mousavi, S., Hosseini, A., & Shidfar, F. (2016). Regression of non-alcoholic fatty liver by vitamin D supplement: A double-blind randomized controlled clinical trial. Arch Iran Med, 19(9), 631-638. doi:0161909/AIM.006.
Romero-Aroca, P., Navarro-Gil, R., Valls-Mateu, A., Sagarra-Alamo, R., Moreno-Ribas, A., & Soler, N. (2017). Differences in incidence of diabetic retinopathy between type 1 and 2 diabetes mellitus: A nine-year follow-up study. British Journal of Ophthalmology, 1-7. doi:10.1136/bjophthalmol-2016-310063.